Recent advances in the molecular design and applications of proteolysis targeting chimera-based multi-specific antiviral modality
Viral infections represent a major threat to human health and the global economy; however, most of the currently available antiviral drugs are not fully effective in restricting viral replication and selecting for drug-resistant variants. Targeted protein degradation technologies are promising strat...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Book |
| Published: |
Compuscript Ltd,
2023-08-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000 am a22000003u 4500 | ||
|---|---|---|---|
| 001 | doaj_f42ea702933c4c6284817f88fde8b8d8 | ||
| 042 | |a dc | ||
| 100 | 1 | 0 | |a Yang Zhou |e author |
| 700 | 1 | 0 | |a Shujing Xu |e author |
| 700 | 1 | 0 | |a Nerea López-Carrobles |e author |
| 700 | 1 | 0 | |a Dang Ding |e author |
| 700 | 1 | 0 | |a Xinyong Liu |e author |
| 700 | 1 | 0 | |a Luis Menéndez-Arias |e author |
| 700 | 1 | 0 | |a Peng Zhan |e author |
| 245 | 0 | 0 | |a Recent advances in the molecular design and applications of proteolysis targeting chimera-based multi-specific antiviral modality |
| 260 | |b Compuscript Ltd, |c 2023-08-01T00:00:00Z. | ||
| 500 | |a 2737-7946 | ||
| 500 | |a 10.15212/AMM-2023-0019 | ||
| 520 | |a Viral infections represent a major threat to human health and the global economy; however, most of the currently available antiviral drugs are not fully effective in restricting viral replication and selecting for drug-resistant variants. Targeted protein degradation technologies are promising strategies to avoid or delay the emergence of drug resistance. Among the protein degradation-based multi-specific approaches, proteolysis targeting chimera (PROTAC) is the main strategy applied in the antiviral field. In this review we will introduce the elements and mechanisms of action used by PROTAC technology, as well as the advantages of PROTACs over available antiviral drugs. We also summarize the latest progress in the application of PROTACs in antiviral research, discuss existing challenges and look into future opportunities for antiviral drug discovery. | ||
| 546 | |a EN | ||
| 690 | |a viruses | ||
| 690 | |a antiviral drugs | ||
| 690 | |a targeted protein degradation | ||
| 690 | |a protac | ||
| 690 | |a multi-specific drugs | ||
| 690 | |a Pharmacy and materia medica | ||
| 690 | |a RS1-441 | ||
| 690 | |a Therapeutics. Pharmacology | ||
| 690 | |a RM1-950 | ||
| 655 | 7 | |a article |2 local | |
| 786 | 0 | |n Acta Materia Medica, Vol 2, Iss 3, Pp 285-298 (2023) | |
| 787 | 0 | |n https://www.scienceopen.com/hosted-document?doi=10.15212/AMM-2023-0019 | |
| 787 | 0 | |n https://doaj.org/toc/2737-7946 | |
| 856 | 4 | 1 | |u https://doaj.org/article/f42ea702933c4c6284817f88fde8b8d8 |z Connect to this object online. |